Journal Article > ResearchFull Text
PLOS One. 2016 March 28; Volume 11 (Issue 3); e0152283.; DOI:10.1371/journal.pone.0152283
Burtscher D, Van der Bergh R, Toktosunov U, Angmo N, Samieva N, et al.
PLOS One. 2016 March 28; Volume 11 (Issue 3); e0152283.; DOI:10.1371/journal.pone.0152283
Kyrgyzstan is one of the 27 high multidrug-resistant tuberculosis (MDR-TB) burden countries listed by the WHO. In 2012, Médecins Sans Frontières (MSF) started a drug-resistant tuberculosis (DR-TB) project in Kara Suu District. A qualitative study was undertaken to understand the perception of TB and DR-TB in order to improve the effectiveness and acceptance of the MSF intervention and to support advocacy strategies for an ambulatory model of care.